MedPath

A clinical trial to study the role of advanced imaging modalities in evaluation of prostate cancer

Phase 4
Conditions
Health Condition 1: C61- Malignant neoplasm of prostate
Registration Number
CTRI/2019/03/018285
Lead Sponsor
Departement of Radiodiagnosis AIIMS New Delhi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)Adult Patient (age in completed years above 18)

2) PSA >5 ng/ml

3) Positive Digital rectal examination

Exclusion Criteria

1) Histopathology other than adenocarcinoma.

2) MRI contraindications like pacemakers.

3) Contraindications for contrast administration like previous h/o reaction to Gadolinium, deranged renal function tests, etc.

4) Poor general condition/ performance status (e.g.- acute heart failure etc.)

5) Non consenting patients.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath